Testing for NTRK Fusions

The Illumina Genomics Podcast

Testing for NTRK Fusions

Nov 11, 2022 | Episode 77 | 7 mins

Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next generation sequencing (NGS)-based testing for NTRK gene fusions. He presents the case of a patient who benefited from precision medicine based on the detection of a NTRK1 fusion by comprehensive genomic profiling.

Download or subscribe to our recurring podcasts.